These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 28353004)
1. The effectiveness of a population-based skin cancer screening program: evidence from Germany. Kaiser M; Schiller J; Schreckenberger C Eur J Health Econ; 2018 Apr; 19(3):355-367. PubMed ID: 28353004 [TBL] [Abstract][Full Text] [Related]
2. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany. Stang A; Jöckel KH Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048 [TBL] [Abstract][Full Text] [Related]
3. The many unanswered questions related to the German skin cancer screening programme. Stang A; Garbe C; Autier P; Jöckel KH Eur J Cancer; 2016 Sep; 64():83-8. PubMed ID: 27371911 [TBL] [Abstract][Full Text] [Related]
4. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015). Stang A; Jöckel KH; Heidinger O Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207 [TBL] [Abstract][Full Text] [Related]
5. Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening. Eisemann N; Waldmann A; Garbe C; Katalinic A Med Decis Making; 2015 Feb; 35(2):243-54. PubMed ID: 25145574 [TBL] [Abstract][Full Text] [Related]
6. Systematic skin cancer screening in Northern Germany. Breitbart EW; Waldmann A; Nolte S; Capellaro M; Greinert R; Volkmer B; Katalinic A J Am Acad Dermatol; 2012 Feb; 66(2):201-11. PubMed ID: 22074699 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of skin cancer screening for individuals age 14 to 34 years. Schmitt J; Seidler A; Heinisch G; Sebastian G J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381 [TBL] [Abstract][Full Text] [Related]
8. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013. Katalinic A; Eisemann N; Waldmann A Dtsch Arztebl Int; 2015 Sep; 112(38):629-34. PubMed ID: 26429634 [TBL] [Abstract][Full Text] [Related]
9. Melanoma mortality following skin cancer screening in Germany. Boniol M; Autier P; Gandini S BMJ Open; 2015 Sep; 5(9):e008158. PubMed ID: 26373399 [TBL] [Abstract][Full Text] [Related]
10. Melanoma screening: A plan for improving early detection. Shellenberger R; Nabhan M; Kakaraparthi S Ann Med; 2016; 48(3):142-8. PubMed ID: 26911192 [TBL] [Abstract][Full Text] [Related]
11. Observed and expected mortality in the German skin cancer screening pilot project SCREEN. Eisemann N; Waldmann A; Holleczek B; Katalinic A J Med Screen; 2018 Sep; 25(3):166-168. PubMed ID: 29169295 [TBL] [Abstract][Full Text] [Related]
12. [Skin cancer screening in Germany: review after ten years]. Hübner J; Eisemann N; Brunßen A; Katalinic A Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1536-1543. PubMed ID: 30411137 [TBL] [Abstract][Full Text] [Related]
13. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening. Waldmann A; Nolte S; Weinstock MA; Breitbart EW; Eisemann N; Geller AC; Greinert R; Volkmer B; Katalinic A Br J Cancer; 2012 Feb; 106(5):970-4. PubMed ID: 22294187 [TBL] [Abstract][Full Text] [Related]
14. Barriers to Using a Nationwide Skin Cancer Screening Program: Findings from Germany. Görig T; Schneider S; Schilling L; Diehl K Oncol Res Treat; 2018; 41(12):774-779. PubMed ID: 30458453 [TBL] [Abstract][Full Text] [Related]
15. [Malignant melanoma of the skin: does screening for cancer influence the incidence and mortality?]. Schubert A Gesundheitswesen; 2012 Mar; 74(3):154-9. PubMed ID: 21305450 [TBL] [Abstract][Full Text] [Related]
16. Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease severity. Trautmann F; Meier F; Seidler A; Schmitt J Br J Dermatol; 2016 Nov; 175(5):912-919. PubMed ID: 27203791 [TBL] [Abstract][Full Text] [Related]
17. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening. Hübner J; Waldmann A; Eisemann N; Noftz M; Geller AC; Weinstock MA; Volkmer B; Greinert R; Breitbart EW; Katalinic A Eur J Cancer Prev; 2018 Nov; 27(6):563-569. PubMed ID: 28692584 [TBL] [Abstract][Full Text] [Related]
18. Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations. Waldmann A; Nolte S; Geller AC; Katalinic A; Weinstock MA; Volkmer B; Greinert R; Breitbart EW Arch Dermatol; 2012 Aug; 148(8):903-10. PubMed ID: 22911184 [TBL] [Abstract][Full Text] [Related]
19. Skin cancer screening campaign in the German speaking Community of Belgium. Nikkels AF; Nikkels-Tassoudji N; Jerusalem-Noury E; Sandman-Lobusch H; Sproten G; Zeimers G; Schroeder J; Piérard GE Acta Clin Belg; 2004; 59(4):194-8. PubMed ID: 15597726 [TBL] [Abstract][Full Text] [Related]
20. [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein]. Eisemann N; Waldmann A; Katalinic A Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):77-83. PubMed ID: 24357176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]